Liver damage in human small intestinal bacterial overgrowth

Area of Science:

• Gastroenterology
• Hepatology
• Microbiology

Background:

• Small intestinal bacterial overgrowth (SIBO) is linked to hepatic damage in rodents, potentially due to increased intestinal permeability.
• Human data on SIBO prevalence and associated liver damage are limited.
• This study investigates the relationship between SIBO and liver damage in adult humans.

Purpose of the Study:

• To determine the prevalence of hepatic damage in human subjects with SIBO.
• To investigate the association between specific types of bacterial overgrowth and liver injury.
• To assess the role of small intestinal permeability in SIBO-related liver damage.

Main Methods:

• Bacteriological analysis of small intestinal aspirates was performed on 70 adult subjects.
• Serum liver enzymes (ALP, GGT, AST, ALT) and nutritional indices were measured.
• Urinary lactulose/mannitol ratio assessed small intestinal permeability in subjects with SIBO and liver damage.

Main Results:

• SIBO was detected in 57.1% of subjects.
• Liver damage was observed in only one of eight subjects with SIBO involving obligate anaerobic colonic bacteria (12.5%).
• Increased small intestinal permeability was noted in some SIBO patients, normalizing after treatment; it did not always correlate with liver damage.

Conclusions:

• SIBO is not a major risk factor for liver damage in humans, irrespective of bacterial type.
• Increased small intestinal permeability associated with SIBO does not invariably result in liver damage.
• The findings suggest a low direct risk of hepatic injury from SIBO in this patient population.